肠胃综合征可能对增加的托芬代谢物水平产生因果作用:双向双样本孟德尔随机化研究的见解
Peilin Cheng1, Ruzhen Jia1, Bingjie Jin1
1Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
International journal of tryptophan research : IJTR
|June 27, 2025
概括
刺激性肠综合征 (IBS) 可能会增加托,血清素和金氨酸的水平. 没有发现托芬代谢物会导致IBS,这表明这些化合物在IBS病变发生过程中可能发挥作用.
科学领域:
- 胃肠病学 胃肠病学
- 代谢学 代谢学 代谢学
- 遗传学 是一个遗传学.
背景情况:
- 刺激性肠综合征 (IBS) 是一种常见的功能性胃肠疾病.
- 肠道微生物群的托芬代谢越来越多地与胃肠道疾病有关.
- 托代谢物和IBS之间的确切关系需要进一步研究.
研究的目的:
- 调查托代谢物和IBS之间的潜在因果关系.
- 用门德尔的随机化 (MR) 来评估遗传关联.
主要方法:
- 用了全基因组关联研究 (GWAS) 的数据,用于托芬代谢物和IBS.
- 进行了双向的双样本孟德尔随机化分析.
- 进行了敏感性分析,包括MR-Egger回归和MR-PRESSO,以评估型性和确定异常值.
主要成果:
- 没有观察到基因预测的托代谢物对IBS风险的显著因果作用.
- 基因预测的IBS显示与托,血清激素和 kynurenine 的水平增加有显著的关联.
- 敏感性和复制性分析支持了这些发现.
结论:
- 肠胃综合征可能会因果地影响托芬代谢,导致托芬,血清激素和 kynurenine 的水平升高.
- 这些发现凸显了IBS和托代谢途径之间潜在的双向关系.
- 需要进一步的研究来阐明这些关联背后的机制.
相关概念视频
Irritable Bowel Syndrome I: Introduction
399
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
399
Drugs for Treatment of Diarrhea-Predominant IBS
312
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
312
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
255
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
255
Drugs for Treatment of Constipation-Predominant IBS
351
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
351
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
430
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
430
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
413
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
413


